The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Monoclonal Antibody Therapy-Global Market Insights and Sales Trends 2024
Synopsis
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The global Monoclonal Antibody Therapy market size is expected to reach US$ 190750 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibody Therapy in various end use industries. The expanding demands from the Cancer, Autoimmune Diseases and Others,, are propelling Monoclonal Antibody Therapy market. Human Monoclonal Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Humanized Monoclonal Antibody segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibody Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibody Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibody Therapy covered in this report include Abbvie, Amgen, Glaxosmithkline, Merck, Novartis, Roche, Johson & Johson and Novartis, etc.
The global Monoclonal Antibody Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
Global Monoclonal Antibody Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Therapy market, Segment by Type:
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody
Global Monoclonal Antibody Therapy market, by Application
Cancer
Autoimmune Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
The global Monoclonal Antibody Therapy market size is expected to reach US$ 190750 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibody Therapy in various end use industries. The expanding demands from the Cancer, Autoimmune Diseases and Others,, are propelling Monoclonal Antibody Therapy market. Human Monoclonal Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Humanized Monoclonal Antibody segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibody Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibody Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibody Therapy covered in this report include Abbvie, Amgen, Glaxosmithkline, Merck, Novartis, Roche, Johson & Johson and Novartis, etc.
The global Monoclonal Antibody Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
Global Monoclonal Antibody Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Therapy market, Segment by Type:
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody
Global Monoclonal Antibody Therapy market, by Application
Cancer
Autoimmune Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Monoclonal Antibody Therapy
1.1 Monoclonal Antibody Therapy Market Overview
1.1.1 Monoclonal Antibody Therapy Product Scope
1.1.2 Monoclonal Antibody Therapy Market Status and Outlook
1.2 Global Monoclonal Antibody Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Monoclonal Antibody Therapy Market Size by Region (2018-2029)
1.4 Global Monoclonal Antibody Therapy Historic Market Size by Region (2018-2023)
1.5 Global Monoclonal Antibody Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Monoclonal Antibody Therapy Market Size (2018-2029)
1.6.1 North America Monoclonal Antibody Therapy Market Size (2018-2029)
1.6.2 Europe Monoclonal Antibody Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Monoclonal Antibody Therapy Market Size (2018-2029)
1.6.4 Latin America Monoclonal Antibody Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Monoclonal Antibody Therapy Market Size (2018-2029)
2 Monoclonal Antibody Therapy Market by Type
2.1 Introduction
2.1.1 Human Monoclonal Antibody
2.1.2 Humanized Monoclonal Antibody
2.1.3 Chimeric Monoclonal Antibody
2.1.4 Murine Monoclonal Antibody
2.2 Global Monoclonal Antibody Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Monoclonal Antibody Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Monoclonal Antibody Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Monoclonal Antibody Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Monoclonal Antibody Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Monoclonal Antibody Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Monoclonal Antibody Therapy Revenue Breakdown by Type (2018-2029)
3 Monoclonal Antibody Therapy Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Autoimmune Diseases
3.1.3 Others
3.2 Global Monoclonal Antibody Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Monoclonal Antibody Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Monoclonal Antibody Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Monoclonal Antibody Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Monoclonal Antibody Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Monoclonal Antibody Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Monoclonal Antibody Therapy Revenue Breakdown by Application (2018-2029)
4 Monoclonal Antibody Therapy Competition Analysis by Players
4.1 Global Monoclonal Antibody Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapy as of 2022)
4.3 Date of Key Players Enter into Monoclonal Antibody Therapy Market
4.4 Global Top Players Monoclonal Antibody Therapy Headquarters and Area Served
4.5 Key Players Monoclonal Antibody Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Monoclonal Antibody Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbvie
5.1.1 Abbvie Profile
5.1.2 Abbvie Main Business
5.1.3 Abbvie Monoclonal Antibody Therapy Products, Services and Solutions
5.1.4 Abbvie Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Abbvie Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Monoclonal Antibody Therapy Products, Services and Solutions
5.2.4 Amgen Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 Glaxosmithkline
5.3.1 Glaxosmithkline Profile
5.3.2 Glaxosmithkline Main Business
5.3.3 Glaxosmithkline Monoclonal Antibody Therapy Products, Services and Solutions
5.3.4 Glaxosmithkline Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Monoclonal Antibody Therapy Products, Services and Solutions
5.4.4 Merck Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Monoclonal Antibody Therapy Products, Services and Solutions
5.5.4 Novartis Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Monoclonal Antibody Therapy Products, Services and Solutions
5.6.4 Roche Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Johson & Johson
5.7.1 Johson & Johson Profile
5.7.2 Johson & Johson Main Business
5.7.3 Johson & Johson Monoclonal Antibody Therapy Products, Services and Solutions
5.7.4 Johson & Johson Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Johson & Johson Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Monoclonal Antibody Therapy Products, Services and Solutions
5.8.4 Novartis Monoclonal Antibody Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
6 North America
6.1 North America Monoclonal Antibody Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monoclonal Antibody Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monoclonal Antibody Therapy Market Dynamics
11.1 Monoclonal Antibody Therapy Industry Trends
11.2 Monoclonal Antibody Therapy Market Drivers
11.3 Monoclonal Antibody Therapy Market Challenges
11.4 Monoclonal Antibody Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
